Sodium apolate: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 48: | Line 48: | ||
[[Category:Sodium compounds]] | [[Category:Sodium compounds]] | ||
[[Category:Vinyl polymers]] | [[Category:Vinyl polymers]] | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Cardiovascular Drugs]][[Category: | [[Category:Drug]] | ||
Revision as of 16:36, 15 April 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | (C2H3NaO3S)n, with n~25 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Sodium apolate (INN) or lyapolate sodium (USAN) is a vasoprotective.
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Sodium compounds
- Vinyl polymers
- Cardiovascular Drugs
- Drug